Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal Botox for Hypertrophic Scars
NCT03631368Phase 2Unknown
- Start
- Oct 2018
- Primary completion
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in Hypertrophic Scar (HS). Primary endpoint: Subject and Observer Scar Assessment Scale. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT03631368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03631368.